PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2013. Start Trial.
Date Value
November 19, 2026 1.269
November 18, 2026 1.269
November 17, 2026 1.269
November 16, 2026 1.269
November 13, 2026 1.269
November 12, 2026 1.269
November 11, 2026 1.269
November 10, 2026 1.269
November 09, 2026 1.269
November 06, 2026 1.269
November 05, 2026 1.269
November 04, 2026 1.269
November 03, 2026 1.269
November 02, 2026 1.269
October 30, 2026 1.269
October 29, 2026 1.269
October 28, 2026 1.269
October 27, 2026 1.269
October 26, 2026 1.269
October 23, 2026 1.269
October 22, 2026 1.269
October 21, 2026 1.269
October 20, 2026 1.269
October 19, 2026 1.269
October 16, 2026 1.269
Date Value
October 15, 2026 1.269
October 14, 2026 1.269
October 13, 2026 1.269
October 12, 2026 1.269
October 09, 2026 1.269
October 08, 2026 1.269
October 07, 2026 1.269
October 06, 2026 1.269
October 05, 2026 1.269
October 02, 2026 1.269
October 01, 2026 1.269
September 30, 2026 1.269
September 29, 2026 1.269
September 28, 2026 1.269
September 25, 2026 1.269
September 24, 2026 1.269
September 23, 2026 1.269
September 22, 2026 1.269
September 21, 2026 1.269
September 18, 2026 1.269
September 17, 2026 1.269
September 16, 2026 1.269
September 15, 2026 1.269
September 14, 2026 1.269
September 11, 2026 1.269

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA 1.758
Genfit SA 7.617
Innate Pharma SA 17.86
Inventiva SA 14078.05

PS Ratio Related Metrics